COCONUT CREEK, FLORIDA - EQS - NutraLife Biosciences,Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) hasreceived two licenses from the Wisconsin Department of Agriculture to grow andprocess industrial hemp within the state. The Company plans to developefficient, cost reducing growing systems and processing technologies forindustrial hemp.

Edgar Ward, Founder and CEO ofNutraLife, commented: "As a company entering the bio-life sciences spaceit is our goal to become vertically integrated as a trusted supplier of rawbulk materials and insure the efficacy and quality of the productsproduced."

According to a recent Hemp Industry Daily report, Wisconsin was deemed a 'new andemerging market' for hemp and hemp production. The report also names Wisconsinthe 'fastest-moving state yet to allow hemp industry to take root.' Other upand coming states include California and Virginia, to name a few.

The Company's in-house productsinclude the NutraHempCBD andNutraSpray brands. The Company manufactures 100% of its in-house products atits FDA approved facility in accordance with GMP. The Company developed itsfirst branded products in 2013. The Company's product development, testing andresearch is conducted by four chemists under the supervision of Mr. Ward.

NutraLife Biosciences, Inc.,formerly known as NutraFuels, Inc., ("NutraLife" or the"Company") also recently announced a name change to NutraLifeBioSciences, Inc. and new stock trading symbol, NLBS. The Company believes thatthe name, NutraLife BioSciences better reflects its current and planned futureoperations.

The Company is a fullyreporting company with a class of securities registered with the U.S.Securities and Exchange Commission ("SEC"). The Company recentlyannounced its financial results for the three (3) and nine (9) month periodended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectivelycompared to $652,385 and $1,027,727 for the three (3) and nine (9) month periodended September 30, 2017. NTFU's filings with the SEC can be viewed at www.sec.gov. NTFU's CBD productsand information about the company's direct sales program can be found online at www.nutrahempcbd.com and by following the companyon Instagram.

* These statements have notbeen evaluated by the Food and Drug Administration.

* This product is not intendedto diagnose, treat, cure or prevent any disease.

Forward-Looking Statements
This communication contains statements of a forward-looking nature aboutNutraLife BioSciences, Inc., (the "Company"). These statements aremade under the "safe harbor" provisions of the U.S. PrivateSecurities Litigation Reform Act of 1995. You can identify theseforward-looking statements by words or phrases such as "may,""will," "except," "anticipate," "aim,""estimate," "intend," "plan,""believe," "is/are likely to," "future" or othersimilar expressions. The Company has based these forward-looking statementslargely on the Company's current expectations and projections about futureevents and financial trends that the Company believes may affect Company'sfinancial condition, results of operations, business strategy, and financialneeds. There is no assurance that the Company's current expectations andprojections are accurate. All forward-looking statements in this press releaseare based on information available to the Company on the date hereof. Thesestatements involve known and unknown risks, uncertainties and other factorsthat may cause the Company's actual results to differ materially from thoseimplied by the forward-looking statements. More detailed information aboutthese risk factors are set forth in the Company's filings with the Securitiesand Exchange Commission, including, but not limited to, those risks anduncertainties listed in the section entitled "Risk Factors," in theCompany's Annual Report on Form 10-K with the Securities and ExchangeCommission on April 17, 2018. The Company operates in a rapidly evolvingenvironment. New risk factors emerge from time to time, and it is impossiblefor the Company's management to predict all risk factors, nor can the Companyassess the impact of all factors on Company's business or the extent to whichany factor, or combination of factors, may cause actual results to differ fromthose contained in any forward-looking statement. The Company does notundertake any obligation to update or revise the forward-looking statementsexcept as required under applicable law.